Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

How Large Is the Psychedelic Drugs Market Expected to Be in 2029?

The market size for psychedelic drugs has experienced aggressive expansion over the recent past. The market, which was valued at $5.56 billion in 2024, is projected to increase to $6.33 billion in 2025, recording a compound annual growth rate (CAGR) of 13.9%. Factors contributing to this growth during the historic period include changes in regulatory systems, a surge in mental health consciousness, as well as evolving public attitudes.

It is anticipated that the psychedelic drugs market will experience swift expansion in the coming years, projected to hit “$11.68 billion by 2029 with a compound annual growth rate (CAGR) of 16.5%.” This forthcoming growth period will be driven by factors such as advances in drug development, broader therapeutic applications, increased acceptance within the medical profession, changes in public policies, and a response to the mental health crisis. Key trends that will emerge in this forecast period encompass increased emphasis on education and public awareness, legal changes and regulatory advancements, the broadening array of psychedelic compounds, and treatment approaches orientated around the patient.

Download The Free Sample Report Here:

https://www.thebusinessresearchcompany.com/sample.aspx?id=6345&type=smp

What Are The Contributors To Demand In The Psychedelic Drugs Market?

The escalation in mental illness incidences is projected to fuel the expansion of the psychedelic drugs market in the future. Mental illnesses are health issues characterized by alterations in feelings, cognition, or behavior. These illnesses encompass discomfort and post-traumatic stress disorder. Psychedelic drugs, which are employed to manage depression and post-traumatic stress disorder, can reduce mental illnesses with consistent use. For example, the National Centre for Social Research, a social research institution based in the UK, reported in November 2022 that the percentage of 17- to 19-year-olds suspected of having a mental disorder rose from 17.4% in 2021 to 25.7% in 2022. Thus, the swelling number of mental illness cases is stimulating the growth of the psychedelic drugs market.

The psychedelic drugs market covered in this report is segmented –

1) By Type: Lysergic Acid Diethylamide (LSD), Ketamine, Phencyclidine, Gamma Hydroxybutyric Acid (GHB), Salvia

2) By Disease Indication: Depression, PTSD

3) By Origin: Natural, Synthetic

4) By Application: Treatment-Resistant Depression, Opiate addiction, Post- Traumatic Stress Disorder, Narcolepsy, Panic Disorders

5) By Distribution Channel: Hospitals Pharmacy, Retail Pharmacy, Online Pharmacy

Subsegments:

1) By Lysergic Acid Diethylamide (LSD): LSD Tablets, LSD Liquid, LSD Blotters

2) By Ketamine: Ketamine Infusion, Ketamine Nasal Spray, Ketamine Injectable

3) By Phencyclidine (PCP): PCP Powder, PCP Tablets, PCP Liquid

4) By Gamma Hydroxybutyric Acid (GHB): GHB Liquid, GHB Powder, GHB Capsules

5) By Salvia: Salvia Extract, Salvia Dried Leaves, Salvia Tinctures

What Future Market Trends Are Projected For The Psychedelic Drugs Industry?

Leading entities in the psychedelic drugs market are concentrating their efforts on the development of novel products such as ketamine. They aim to enhance therapeutic results for mental health disorders, broaden patient access to these treatments, and investigate the potential uses of psychedelic substances for conditions like depression, anxiety, PTSD, and substance use disorders. Ketamine, known for its distinctive anesthetic and analgesic properties, is now being studied for its swift antidepressant effects, particularly in treating severe depression and PTSD. In March 2022, for example, the traditional American company Husch Blackwell established the Psychedelics and Emerging Therapies Practice Group. The aim of this practice group is to support pioneers in their quest to research, develop, and bring to market cutting-edge psychedelic-based therapies. The group is made up of a diversified team of legal experts who specialize in navigating the intricate laws associated with these often Schedule I classified controlled substances under U.S. federal law. This status poses significant regulatory obstacles that could impede research and development ventures.

Who Are The Top-Ranked Companies In The Psychedelic Drugs Market Today?

Major companies operating in the psychedelic drugs market include Atai Life Sciences, Cybin Inc., Mind Medicine Inc., Compass Pathways, Seelos Therapeutics, Numinus Wellness Inc., GH Research, Revive Therapeutics, Havn Life Sciences, PharmaTher Holdings, Field Trip Health, Small Pharma, Incannex Healthcare, Optimi Health, NeonMind Biosciences, Entheon Biomedical, Mydecine Innovations Group, Red Light Holland, Eleusis, MAPS Public Benefit Corporation, Beckley Psytech, Awakn Life Sciences, Psygen Industries, Enveric Biosciences, Filament Health, Tactogen, Bexson Biomedical, BetterLife Pharma, Clairvoyant Therapeutics, Universal Ibogaine

https://www.thebusinessresearchcompany.com/report/psychedelic-drugs-global-market-report

How Is Psychedelic Drugs Market Adoption Varying Across Different Regions And Sectors?

North America was the largest region in the psychedelic drugs market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the psychedelic drugs market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request For A Customized Report:

https://www.thebusinessresearchcompany.com/customise?id=6345&type=smp

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model